Significance of pentraxin-3 in patients with juvenile scleroderma
Adrovic, A.; Sahin, S.; Barut, K.; Durmus, S.; Uzun, H.; Kasapcopur, O.
Clinical and Experimental Rheumatology 35 Suppl 106(4): 221-222
2017
ISSN/ISBN: 0392-856X PMID: 28664833 Document Number: 692684
Document emailed within 1 workday
Related Documents
Ishikawa, H.; Suzuki, S.; Horiuchi, R.; Sato, H. 1975: An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma Acta Dermato-Venereologica 55(2): 97-107Deniz, T.; Kizilgul, M.; Uzunlulu, M.; Oguz, A.; Isbilen, B. 2014: Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis Acta Reumatologica Portuguesa 39(2): 137-142
Garza-Elizondo, M.A.; Diaz-Jouanen, E.; Franco-Casique, J.J.; Alarcón-Segovia, D. 1983: Joint contractures and scleroderma-like skin changes in the hands of insulin-dependent juvenile diabetics Journal of Rheumatology 10(5): 797-800
Ziegler, V.; Haustein, U.F.; Mehlhorn, J.; Münzberger, H.; Rennau, H. 1986: Quartz-induced scleroderma. Scleroderma-like syndrome or true progressive scleroderma? Dermatologische Monatschrift 172(2): 86-90
Kravchun, P.G.; Kadykova, O.I.; Molotyagin, D.G. 2019: Changes in pentraxin-3 level and its interaction with metabolic indices in patients with coronary artery disease and type 2 diabetes mellitus Wiadomosci Lekarskie 72(2): 181-185
Jordon, R.E.; Deheer, D.; Schroeter, A.; Winkelmann, R.K. 1971: Antinuclear antibodies: their significance in scleroderma Mayo Clinic Proceedings 46(2): 111-113
Sönnichsen, N.; Brenke, A.; Barthelmes, H.; Albrecht-Nebe, H.; Diezel, W. 1983: Immunologic findings in progressive scleroderma--diagnostic and nosologic significance Dermatologische Monatschrift 169(6): 385-393
Behr, J.; Adelmann-Grill, B.C.; Hein, R.; Schwaiblmair, M.; Degenkolb, B.; Krombach, F.; Fruhmann, G. 1995: Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts Pneumologie 49(4): 266-272
Albrecht, J.; Simon, C. 1980: Current significance of juvenile salmonella infections DieMedizinischeWelt 31(51-52): 1879
Vasiukova, E.A.; Kasatkina, E.P.; Kurmanova, A.K. 1973: Genesis and prognostic significance of juvenile hypercorticism Voprosy Okhrany Materinstva i Detstva 18(6): 48-52
Parker, M.D. 1973: Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease Journal of Laboratory and Clinical Medicine 82(5): 769-775
De la Espriella, J.; Crickx, B. 1991: Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs Annales de Dermatologie et de Venereologie 118(12): 948-953
Giordano, M.; Valenti, G. 1986: Linear scleroderma plus systemic sclerosis sine scleroderma plus neuromyopathy of one upper limb: a new entity? Journal of Rheumatology 13(3): 656-657
Pope, J.E.; Bellamy, N. 1995: Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials Clinical and Investigative Medicine 18(1): 1-10
Land, W. 1982: Pancreas transplantation. Current significance in the treatment of juvenile diabetes mellitus Münchener Medizinische Wochenschrift 124(4): 71-73
Madsen, K.L.; Hansen, A.; Halberg, P.; Ullman, S. 2014: Development of scleroderma renal crisis in a patient with undiagnosed scleroderma Ugeskrift for Laeger 176(25a)
Jablonska, S.; Blaszczyk, M. 1999: Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis European Journal of Dermatology: Ejd 9(7): 551-554
Kochetov, D.P.; Krivosheev, B.N. 1976: Scleroderma and porphyria cutanea tarda with clinical manifestations of scleroderma Vestnik Dermatologii i Venerologii 1: 64-68
Haustein, U.F.; Ziegler, V. 1986: Scleroderma and scleroderma-like diseases caused by environmental pollutants Dermatosen in Beruf und Umwelt. Occupation and Environment 34(3): 61-67
Black, C.M. 1994: Prognosis and management of scleroderma and scleroderma-like disorders in children Clinical and Experimental Rheumatology 12(Suppl 10): S75-S81